Inotiv, Inc. (NOTV)
NASDAQ: NOTV · Real-Time Price · USD
2.210
+0.060 (2.79%)
At close: Mar 31, 2025, 4:00 PM
2.172
-0.038 (-1.71%)
After-hours: Mar 31, 2025, 7:55 PM EDT
Inotiv Market Cap
Inotiv has a market cap or net worth of $74.85 million as of March 31, 2025. Its market cap has decreased by -64.94% in one year.
Market Cap
74.85M
Enterprise Value
483.92M
1-Year Change
-64.94%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since December 1, 1998, Inotiv's market cap has increased from $20.80M to $74.85M, an increase of 259.86%. That is a compound annual growth rate of 4.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 72.80M | -32.40% |
| Dec 31, 2024 | 107.70M | 13.73% |
| Dec 29, 2023 | 94.70M | -25.08% |
| Dec 30, 2022 | 126.40M | -87.62% |
| Dec 31, 2021 | 1.02B | 650.66% |
| Dec 31, 2020 | 136.00M | 161.54% |
| Dec 31, 2019 | 52.00M | 300.00% |
| Dec 31, 2018 | 13.00M | -35.64% |
| Dec 29, 2017 | 20.20M | 225.81% |
| Dec 30, 2016 | 6.20M | -49.59% |
| Dec 31, 2015 | 12.30M | -30.11% |
| Dec 31, 2014 | 17.60M | -15.79% |
| Dec 31, 2013 | 20.90M | 100.96% |
| Dec 31, 2012 | 10.40M | 19.54% |
| Dec 30, 2011 | 8.70M | -29.84% |
| Dec 31, 2010 | 12.40M | 143.14% |
| Dec 31, 2009 | 5.10M | -23.88% |
| Dec 31, 2008 | 6.70M | -84.27% |
| Dec 31, 2007 | 42.60M | 58.36% |
| Dec 29, 2006 | 26.90M | -1.82% |
| Dec 30, 2005 | 27.40M | 12.76% |
| Dec 31, 2004 | 24.30M | 34.25% |
| Dec 31, 2003 | 18.10M | 44.80% |
| Dec 31, 2002 | 12.50M | -60.94% |
| Dec 31, 2001 | 32.00M | 201.89% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.46B |
| UnitedHealth Group | 481.27B |
| Johnson & Johnson | 399.75B |
| AbbVie | 369.19B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 229.52B |
| Merck & Co. | 226.07B |
| AstraZeneca | 225.46B |